U.S. FDA Fast Track designation granted to AKY-1189 1 for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have progressed on or after prior systemic therapies ...
SHENZHEN, China, Dec. 24, 2025 /PRNewswire/ -- AKEEYO is elevating vehicle intelligence at CES 2026 with two revolutionary camera systems. The AKY-NV-X2 11-inch mirror dash cam serves automobile ...
Aktis Oncology (NASDAQ:AKTS) used a presentation at TD Cowen’s 46th Annual Healthcare Conference to outline its strategy to broaden the reach of targeted radiopharmaceutical therapy beyond today’s mos ...
A breakthrough in cancer treatment may soon change how some of the most aggressive tumors are managed. A small, specially-designed protein known as AKY-1189 has shown it can carry radiation directly ...
FDA fast track enables increased FDA-company interactions and potential rolling BLA submission to accelerate development for serious diseases with unmet need. AKY-1189 uses a miniprotein ...
The FDA has granted Fast Track Designation to AKY-1189 (actinium-225; 225 Ac) a potent alpha-emitting radioisotope in the potential treatment of Nectin-4 expressing tumors in urothelial carcinoma. 1 ...
11-inch IPS touchscreen with crisp 1080P resolution Sony STARVIS image sensor with an F1.0 aperture for excellent low-light performance. Dual 2K cameras with optional 1080p third-channel recording.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results